This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Merck Sharp + Dohme B.v., Tesaro, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 55 
1 out of 18 Years Active: 2024
Title: The Innovative Contributions of Peng Sun in Cancer Treatment
Introduction
Peng Sun is a notable inventor based in New Providence, NJ (US). He has made significant strides in the field of cancer treatment through his innovative approaches. His work focuses on combination therapies that target specific cancer pathways, showcasing his commitment to advancing medical science.
Latest Patents
Peng Sun holds a patent for "Combination therapies for treating cancer." This invention provides methods of treatment for recurrent cancers through combination therapy with an agent that inhibits programmed death-1 protein (PD-1) signaling and an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling. This patent highlights his dedication to developing effective cancer therapies.
Career Highlights
Throughout his career, Peng Sun has worked with prominent companies in the pharmaceutical industry, including Tesaro, Inc. and Merck Sharp & Dohme B.V. His experience in these organizations has contributed to his expertise in cancer research and treatment methodologies.
Collaborations
Peng Sun has collaborated with esteemed colleagues such as Dmitri Bobilev and Bruce Dezube. These partnerships have likely enhanced his research and development efforts in the field of oncology.
Conclusion
Peng Sun's contributions to cancer treatment through innovative combination therapies demonstrate his significant impact on medical research. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile